The CBD Life Sciences (OTCMKTS:CBDL) stock is on the move this morning after releasing a corporate overview.
This morning the Chief Executive Officer and President of CBD Life Sciences Lisa Nelson provided an update with regards to the strategic overview of the company to the shareholders. Nelson went through some of the key highlights.
As of noon, shares of CBDL are trading at .0023 up 53% on the day. Volume is 1.6 billion shares on 3400 trades. Today is the first nice up day since early March. Keep CBDL on your watchlist to see if it continues to gain momentum.
Nelson pointed out that the passing of the Prop 207 move was a landmark for the company since it legalized adult-use recreational cannabis in Arizona, the company’s home state.
CBD Life Sciences Inc. has fantastic news for the shareholders regarding Amazon, one of the biggest online distributors in the world. The company is currently waiting on verification of the trademark for LBC Bioscience Inc. and after that is completed, the company will begin selling its Hemp products on the platform.
In addition, CBD Life Sciences (OTCMKTS:CBDL) is participating in two trade shows this month. One of those is going to take place in Mesa in Arizona later on in April and the other one is going to be held in September in Las Vegas. Investors could consider keeping an eye on the stock today.
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC’s products can be viewed and purchased on the Company’s website at www.lbcbioscienceinc.com.